Revised May 7, 2009

Seminar Series


2007-2008 Gene Therapy Center Seminar Series
September 2007 GTC Seminar Series Co-sponsored by the Center for Neurodegeneration and Experimental Therapeutics (CNET) Wednesday, September 26, 2007 Maria Castro, Ph.D. Co-Director, Gene Therapeutics Research Institute Cedars-Sinai Medical Center Los Angeles, CA Title: Overcoming immune evasion by brain tumors: linking innate and adaptive immunity using gene-based therapeutics Place: Bevill Research Building, Rm. 170 October 2007 GTC Seminar Series Co-sponsored by the UAB Gregory Fleming James Cystic Fibrosis Research Center Tuesday, October 16th, 2007 Joseph Zabner, M.D. Professor, Department of Internal Medicine Division of Pulmonary, Critical Care, and Occupational Medicine University of Iowa, Iowa City, Iowa Title: The Adenovirus Receptor and Adenovirus Place: Bevill Research Building, Rm. 170 November 2007 GTC Seminar Series Co-sponsored by the Center for Neurodegeneration and Experimental Therapeutics (CNET) Wednesday, November 28, 2007 Douglas Martin, Ph.D. Assistant Professor Scott-Richey Research Center Auburn University College of Veterinary Medicine Auburn, AL Title: AAV Gene Therapy of Neurodegenerative Disease in a Feline Model Place: Bevill Research Building, Rm. 170 December 2007 GTC Seminar Series Co-sponsored by the Division of Pulmonary, Allergy and Critical Care Medicine Wednesday, December 19, 2007 Steven M. Albelda, M.D. William Maul Measey Professor of Medicine Vice Chief, Pulmonary, Allergy, and Critical Care Division Director of Lung Research; Co-Director, Thoracic Oncology Laboratories University of Pennsylvania Medical Center Abramson Research Center Philadelphia, PA Title: Immuno-gene Therapy for Malignant Mesothelioma: Successes and Challenges Place: Bevill Research Building, Rm. 170 January 2008 GTC Seminar Series, Co-sponsored by the UAB Liver Center Tuesday, January 15, 2008 Mark A. Kay, M.D., Ph.D. Professor Departments of Pediatrics and Genetics Director, Program in Human Gene Therapy Stanford University School of Medicine Stanford, CA Title: RNAi, microRNAs and Gene Therapy Place: Bevill Research Building, Rm. 170 February 2008 GTC Seminar Series Tuesday, February 12, 2008 Christof von Kalle, M.D. Head, Division of Translational Oncology of the German Cancer Research Center National Center for Tumor Diseases (NCT), Heidelberg, Germany. Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany. Division of Experimental Hematology, Cincinnati Children's Research Foundation, Cincinnati, Ohio Title: The clonal fate of gene modified blood cells Place: Bevill Research Building, Rm. 170 March 2008 GTC Seminar Series, Co-sponsored by the UAB Comprehensive Cancer Center Tuesday, March 25, 2008 Frank McCormick, Ph.D, FRS David A. Wood Distinguished Professor of Tumor Biology and Cancer Research Director, UCSF Comprehensive Cancer Center & Cancer Research Institute University of California San Francisco San Francisco, CA Title: Cancer therapy based on the RAS pathway Place: Bevill Research Building, Rm. 170 May 2008 GTC Seminar Series, Co-sponsored by UAB Departments of Pediatrics and Genetics Tuesday, May 6, 2008 Donald B. Kohn, M.D. Professor of Pediatrics Division of Research Immunology/Bone Marrow Transplantation Keck School of Medicine and Children's Hospital University of Southern California Los Angeles, CA Title: Gene Therapy Using Hematopoietic Stem Cells Place: Bevill Research Building, Rm. 170 May 2008 GTC Seminar Series, Co-sponsored by Susan G. Komen for the Cure-North Alabama Affiliate Tuesday, May 20, 2008 Michael Sadelain, M.D. Department of Medicine and Immunology Program Gene Transfer and Somatic Cell Engineering Laboratory Memorial Sloan Kettering Cancer Center New York, NY Title: Targeting tumors with genetically enhanced T lymphocytes Place: Bevill Research Building, Rm. 170
2006-2007 Gene Therapy Center Seminar Series
GTC Seminar Series May 22, 2007 Mark J. van Raaij Ramon y Cajal Researcher School of Pharmacy Department of Biochemistry and Molecular Biology University of Santiago de Compostela Santiago de Compostela, Spain Title: Structures of viral receptor-binding fibers Place: Bevill Building, Room 170 GTC Seminar Series, Co-sponsored by Susan G. Komen for the Cure, North Central Alabama Affiliate April 9, 2007 Dr. Albert B. Deisseroth, M.D., Ph.D. President and Chief Executive Officer Sidney Kimmel Cancer Center San Diego, CA Title: Vaccines for Cancer and Infectious Diseases Place: Bevill Building, Room 170 GTC Seminar Series, Co-sponsored by the UAB Center for Nanoscale Materials and Biointegration Monday, March 19, 2007 Esther H. Chang, Ph.D. Professor of Oncology and Otolaryngology Georgetown University Medical Center Lombardi Comprehensive Cancer Center Georgetown University Hospital Washington, DC Title: Materializing the Potential of Nanomedicine for Cancer Diagnosis and Therapy Place: Hill University Center, Alumni Auditorium GTC Seminar Series February 20, 2007 Laura Timares, Ph.D. Assistant Professor Department of Dermatology University of Alabama at Birmingham Title: Improving immune responses by using apoptosis-resistant dendritic cell vaccines Place: Finley Conference Center/Kaul Human Genetics Building Time: 10:00 AM GTC Seminar Series January 19, 2007 James M. Markert, M.D. Professor Department of Surgery Director, Division of Neurosurgery University of Alabama at Birmingham Title: Oncolytic Viral Therapy Place: Finley Conference Center/Kaul Human Genetics Building GTC Seminar Series, Co-sponsored by The UAB Liver Center December 8, 2006 Jesús Prieto, M.D. Professor of General Pathology University of Navarra, Campus Universitario Pamplona 31080, Spain Title: "Gene Therapy of Experimental Liver Cirrhosis and Viral Hepatitis" Place: Hill University Center - Alumni Auditorium Time: 10:00 AM GTC Seminar Series, Co-sponsored by the UAB Department of Microbiology Monday, November 20, 2006 Carmen San Martin, Ph.D. Assistant Professor Centro Nacional de Biotecnología (C.S.I.C.) Madrid, Spain Title: Polypeptides IX and IIIa: Recent Developments and Open Questions in Adenovirus Structure Place: Bevill Biomedical Research Building, Room 170 Time: 2:00 PM GTC Seminar Series November 7, 2006 John C. Kappes, Ph.D. Associate Professor Department of Medicine Division of Hematology and Oncology University of Alabama at Birmingham Title: Lentiviral Vectors: Biomedical Research Tools and Safety Considerations Place: Finley Conference Center/Kaul Human Genetics Building Time: 9:00 AM GTC Seminar Series, Co-sponsored by the UAB Division of Cardiovascular Disease Tuesday, October 31, 2006 Duncan J. Stewart, M.D. Professor and Director, Division of Cardiology, University of Toronto Head, Division of Cardiology and Associate Director of Research at St. Michael's Hospital Toronto, Ontario, Canada Title: Gene Therapy for Cardiovascular Disease: A Work in Progress Place: Hill University Center (HUC), Alumni Auditorium Time: 10:00 AM GTC Seminar Series Monday, September 25, 2006 Tim M. Townes, Ph.D. Professor and Chairman Department of Biochemistry & Molecular Genetics University of Alabama at Birmingham Title: Globin Gene Regulation and Genetic Therapies for Sickle Cell Disease Place: Finley Conference Center/Kaul Human Genetics Building Time: 9:00 AM
2005-2006 Gene Therapy Center Seminar Series
Gene Therapy Seminar Series Tuesday, May 17, 2006 Richard C. Mulligan, M.D., Ph.D. Mallinckrodt Professor of Genetics Department of Genetics, Harvard Medical School Professor of Pediatrics Children's Hospital Title: TBA Wednesday, April 12, 2006 Inder M. Verma, Ph.D. American Cancer Society Professor of Molecular Biology Laboratory of Genetics Salk Institute for Biological Studies LaJolla, California Title: TBA Gene Therapy Seminar Series Wednesday, February 22, 2006 Joseph C. Glorioso III, Ph.D. Director, Molecular Medicine Institute Professor and Chairman Department of Molecular Genetics and Biochemistry University of Pittsburgh, School of Medicine Pittsburgh, PA Gene Therapy Seminar Series Wednesday, January 18, 2006 Dusty Miller, Ph.D. Professor Department of Pathology Fred Hutchinson Cancer Research Center University of Washington School of Medicine Seattle, WA Title: TBA Gene Therapy Seminar Series Thursday, November 17, 2005 Savio L.C. Woo, Ph.D. Professor and Chairman Department of Gene and Cell Medicine Mount Sinai School of Medicine Title: "Gene Therapy for Cancer" Gene Therapy Seminar Series Tuesday, November 1, 2005 Hongju Wu, Ph.D. Research Assistant Professor Department of Obstetrics/Gynecology Division of Human Gene Therapy Title: "Adenovirus-mediated Gene Delivery for Brain Tumors" Gene Therapy Seminar Series Tuesday, October 4, 2005 Theresa V. Strong, Ph.D. Associate Professor Department of Medicine Division of Hematology/Oncology Title: "Bedside to Bench: Reverse Translational Research Identifies a Potential Role for hDIg in Melanoma"
2004-2005 Gene Therapy Center Seminar Series
Wednesday, May 18, 2005 E. Antonio Chiocca, M.D. Professor and Dardinger Family Professor Department of Neurological Surgery The Ohio State University Columbus, OH "Oncolytic HSV-1 for Brain Tumor Therapy" Wednesday, May 4, 2005 James S. Norris, Ph.D Professor and Chairman Department of Microbiology / Immunology Medical University of South Carolina Charleston, South Carolina "Modification of Ceramide Metabolism to Induce a Pro-Apoptotic Phenotype that Enhances AdFasL Cancer Gene Therapy" Friday, April 1, 2005 Phoebe L. Stewart, Ph.D. Associate Professor Dept. of Molecular Physiology & Biophysics Vanderbilt University Medical Center Nashville, TN "CryoEM Imaging of Adenovirus Vectors and Adenovirus-Antibody Complexes" Tuesday, March 8, 2005 Sarah Ferber, Ph.D. Head of the Endocrine Research Unit Institute of Endocrinology Sheba Medical Center Tel Hashomer, Israel "Liver as a Pancreatic Progenitor Tissue: Potential Cell Replacement Therapy for Diabetes" Co-sponsored by UAB Human Pancreatic Islet Transplant Program Tuesday, February 22, 2005 William C. Aird, M.D. Chief Division of Molecular and Vascular Medicine Department of Medicine Beth Israel Deaconess Medical Center Boston, MA "Understanding Endothelial Heterogeneity" Wednesday, December 15, 2004 R. Scott McIvor, Ph.D. Professor of Genetics, Cell Biology and Development Director, Gene Therapy Program Institute of Human Genetics University of Minnesota Minneapolis, MN "The Sleeping Beauty Transposon System as a Vector for Gene Therapy" Wednesday, November 17, 2004 Robin J. Parks, Ph.D. Scientist Molecular Medicine Program Ottawa Health Research Institute Ottawa, Canada "Adenovirus Protein IX: A Little Protein with a Big Story" Bevill Biomedical Research Building 170 Friday, October 22, 2004 Gary Nabel, M.D., Ph.D. Director Vaccine Research Center National Institutes of Health Bethesda, MD "Viruses, Vectors, and Human Disease" Tuesday, September 28, 2004 Andrea Amalfitano, D.O., Ph.D. Associate Professor of Pediatrics Duke University Durham, NC "Exploring Adenovirus Vector/Host Interactions to Foster Safe and Efficacious Gene Therapy for Human Diseases."
2003-2004 Gene Therapy Center Seminar Series
Tuesday, October 14, 2003 Phillip L. Leopold, Ph.D. Assistant Professor of Biochemistry in Medicine Department of Medicine Division of Pulmonary and Critical Care Medicine New York Weill Cornell Medical Center "Post-Endocytic Trafficking of Adenovirus" Thursday, November 6, 2003 Michael A. Barry, Ph.D. Associate Professor Departments of Molecular and Human Genetics, Immunology Baylor College of Medicine Department of Bioengineering Rice University "Cell Targeting Technologies for Gene Therapy" Thursday, December 18, 2003 Paul B. Fisher, Ph.D. Professor of Clinical Pathology Department of Pathology Columbia University "Is mda-7/IL24 a Magic Bullet for Cancer?" Tuesday, February 24, 2004 Raymond J. Pickles, Ph.D. Assistant Professor of Medicine University of North Carolina at Chapel Hill School of Medicine "Understanding the Target Cell when Developing Viral Vectors for Therapeutic Gene Delivery to the Lung" Tuesday, March 16, 2004 Patrick Hearing, Ph.D. Professor Department of Molecular Genetics and Microbiology Stony Brook University School of Medicine "Regulation of PML Nuclear Body Function During Adenovirus Infection" Thursday, April 1, 2004 Tanja D. de Gruijl, Ph.D. Department of Medical Oncology Division of Immunotherapy Vrije Universiteit Medical Center Amsterdam, The Netherlands "Dendritic Cell-Targeted Adenoviral Gene Transfer for Tumor Immunotherapy" Wednesday, April 28, 2004 Lily Wu, M.D., Ph.D. Assistant Professor Departments of Urology, Pediatrics and Molecular & Medical Pharmacology David Geffen School of Medicine at UCLA "Molecular Imaging and Gene Therapy in Animal Models of Cancer" Thursday, May 20, 2004 Theodore Friedmann, M.D. Professor, Department of Pediatrics Director, Program in Human Gene Therapy University of California, San Diego School of Medicine Thursday, June 17, 2004 John J. Nemunaitis, M.D. Associate Director, Clinical Research US Oncology Mary Crowley Medical Research Center Dallas, TX "Gene Vaccines in Non Small Cell Lung Cancer"
2002-2003 Gene Therapy Center Seminar Series
Wednesday, October 16, 2002 William S.M. Wold, Ph.D. Professor and Chairman Department of Molecular Microbiology & Immunology St. Louis University School of Medicine Tuesday, November 5, 2002 Patrick W.K. Lee, M.D. Professor Department of Microbiology & Infectious Diseases University of Calgary 'Reovirus as an Oncolytic Agent' Wednesday, November 13, 2002 Gerald G. Krueger, M.D. Professor of Dermatology Cumming Presidential Endowed Chair University of Utah 'The Challenge of Using Genetically Modified Fibroblasts As A Vehicle for Gene Therapy' Wednesday, November 20, 2002 Noriyuki Kasahara, M.D., Ph.D. Assistant Professor Departments of Pathology & Biochemistry University of Southern California 'Lentivectors, RCRs, and Trojan Horses: New Strategies for Improving Therapeutic Gene Transfer In Vivo' Wednesday, December 11, 2002 John Hay, M.D. Assistant Professor of Medicine & Pathology New York University School of Medicine 'Strategies to Enhance the Oncolytic Activity of Adenoviral Vectors' Tuesday, January 14, 2003 Dr. Andre Lieber Research Associate Professor University of Washington 'Structural Determinants and Pathways for Adenovirus Infection In Vitro and In Vivo' Wednesday, February 12, 2003 Roberto Cattaneo, Ph.D. Professor of Biochemistry & Molecular Biology Mayo Foundation 'Measles Virus Entry: Mechanisms and Retargeting' Tuesday, March 11, 2003 Katherine High, M.D. Director of Research Hematology Division Children's Hospital of Philadelphia Tuesday, April 22, 2003 D.C. Yu, Ph.D. Director Oncolytic Virus Research Cell Genesys, Inc. Selectively Replicating Oncolytic Adenoviruses: Clinical Progress and Challenges for the next Generation Tuesday, May 13, 2003 Glen N. Barber, Ph.D. Associate Professor Department of Microbiology and Immunology University of Miami School of Medicine
2001-2002 Gene Therapy Center Seminar Series
Wednesday, October 24, 2001 Ronald G. Crystal, M.D. Director, Institute of Genetic Medicine New York Presbyterian Hospital Weill Medical College of Cornell University New York, NY "Genetic Modification of Dendritic Cells to Enhance Host Defenses" Friday, November 16, 2001 K. Dane Wittrup, Ph.D. J.R. Mares Professor Chemical Engineering & Bioengineering Massachusetts Institute of Technology Cambridge, MA "Directed Evolution of Protein Recognition, Stability and Expression by Yeast Surface Display" Friday, January 11, 2002 Per Eystein Lønning, M.D., Ph.D. Professor Department of Oncology Haukeland University Hospital Bergen, Norway "Translational Research on Gene Defects with Respect to Chemoresistance in Cancer" Wednesday, February 6, 2002 Dan J. Von Seggern, Ph.D. Assistant Professor Department of Immunology The Scripps Research Institute La Jolla, CA "Pseudotyped Adenoviruses: Targeted Gene Delivery and Determination of Viral Tropism" West Pavilion E Thursday, February 21, 2002 Jeffrey S. Chamberlain, Ph.D. Professor Department of Neurology University of Washington School of Medicine Seattle, WA "Prevention and Reversal of Muscular Dystrophy by Gene Therapy" March 13-14, 2002 Michael Imperiale, Ph.D. Professor Interim Co-Director, Center for Gene Therapy University of Michigan Medical School Ann Arbor, MI April 18, 2002 Stephen Russell, M.D., Ph.D. Director Molecular Medicine Program Mayo Clinic Rochester, MN "Exploiting Attenuated Measles Viruses for Cancer Therapy" May 14-15, 2002 Malcolm K. Brenner, M.D., Ph.D. Professor of Medicine and of Pediatrics Director, Center for Cell and Gene Therapy Baylor College of Medicine May 30, 2002 Andrew H. Baker, Ph.D. Senior Lecturer in Molecular Medicine Department of Medicine and Therapeutics University of Glasgow, Scotland "Targeted Adenoviral Vectors"
2000-2001 Gene Therapy Center Seminar Series
Tuesday, March 13, 2001 Dr. Roland Kontermann, Ph.D. Phillips-University of Marburg, Germany "Targeting of vectors and effectors with recombinant bispecific antibodies". Thursday, March 22, 2001 Dr. H. M. Pinedo Chair of Medical Oncology Vrije University of Amsterdam Amsterdam, The Netherlands Tuesday, April 24, 2001 Thomas W. Dubensky, Jr., Ph.D. Senior Director of Virus Research, Onyx Pharmaceuticals "The Development of Selectively Replicating Adenoviruses as Cancer Therapeutics: Promise of Clinical Efficacy and Future Directions" Thursday, May 17, 2001 Heshan (Sam) Zhou, Ph.D. Research Assistant Professor Department of Molecular and Human Genetics Center for Cell and Gene Therapy Baylor College of Medicine Houston, TX "Development of Adenovirus Vector System - From E2a Deletion to Gutless Strategy and to Conditional Replication"